Abstract
The pursuit of evidence for the effectiveness of medical interventions was an early characteristic of western medicine. The development of scientific methods to identify the most effective treatment modalities culminated in the concepts and paradigms of evidence-based medicine (EBM) in the second half of the 20th century. The premise of Archie Cochrane, a founder of EBM, that “all treatment must be proved to be effective” is still valid today. Meanwhile, the increasing awareness that many patients do not receive the best standard of care as determined by scientific evidence raised questions on how to better assist physicians in their clinical decision making. This brought the attention to clinical practice guidelines (CPGs), which include graded recommendations developed by experts based on the quality of the available scientific evidence. CPGs are considered one of the most potential tools in helping to improve patient outcomes by providing doctors and patients with information on best-practice standards. While previous approaches for guideline development were often based on tradition or authority, the recommendations found in modern best-practice guidelines are based on standardized methods for grading quality of evidence and strength of recommendation.
In Nephrology this has inspired the development of guidelines by different organizations. While this has certainly led to some improvement in patient care, the uncoordinated approach to guideline development has led to redundancy in some areas of kidney disease management. Therefore, a new initiative, Kidney Disease: Improving Global Outcomes (KDIGO), was founded in 2003 in order to globally coordinate and promote the development of CPGs in nephrology. However, despite the improvement in the development process, there still remain obstacles to the implementation of CPG recommendations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abel, U., Koch, A.: The role of randomization in clinical studies: myths and beliefs. J. Clin. Epidemiol. 52(6), 487–497 (1999)
American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann. Intern. Med. 117(12), 1038–1041 (1992)
Antman, E.M., Lau, J., Kupelnick, B., et al.: A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 268(2), 240–248 (1992)
Atkins, D., Best, D., Briss, P.A., et al.: Grading quality of evidence and strength of recommendations. BMJ 328(7454), 1490 (2004)
Audet, A.M., Greenfield, S., Field, M.: Medical practice guidelines: current activities and future directions. Ann. Intern. Med. 113(9), 709–714 (1990)
Begg, C., Cho, M., Eastwood, S., et al.: Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276(8), 637–639 (1996)
Benson, K., Hartz, A.J.: A comparison of observational studies and randomized, controlled trials. N. Engl. J. Med. 342(25), 1878–1886 (2000)
Bodenheimer, T.: The American health care system–the movement for improved quality in health care. N. Engl. J. Med. 340(6), 488–492 (1999)
Briss, P.A., Zaza, S., Pappaioanou, M., et al.: Developing an evidence-based Guide to Community Preventive Services–methods. The Task Force on Community Preventive Services. Am. J. Prev. Med. 18(suppl. 1), 35–43 (2000)
Byar, D.P., Simon, R.M., Friedewald, W.T., et al.: Randomized clinical trials. Perspectives on some recent ideas. N. Engl. J. Med. 295(2), 74–80 (1976)
Cabana, M.D., Rand, C.S., Powe, N.R., et al.: Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282(15), 1458–1465 (1999)
Chan, A.W., Altman, D.G.: Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 365(9465), 1159–1162 (2005)
Chassin, M.R., Kosecoff, J., Solomon, D.H., Brook, R.H.: How coronary angiography is used. Clinical determinants of appropriateness. JAMA 258(18), 2543–2547 (1987)
Chertow, G.M., Levin, N.W., Beck, G.J., et al.: In-center hemodialysis six times per week versus three times per week. N. Engl. J. Med. 363(24), 2287–2300 (2010)
Claridge, J.A., Fabian, T.C.: History and development of evidence-based medicine. World J. Surg. 29(5), 547–553 (2005)
Collins, A.J., Roberts, T.L., St Peter, W.L., et al.: United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines. Am. J. Kidney Dis. 39(4), 784–795 (2002)
Concato, J., Shah, N., Horwitz, R.I.: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N. Engl. J. Med. 342(25), 1887–1892 (2000)
Dharmarajan, T.S., Nanda, A., Agarwal, B., et al.: Prevention of Venous Thromboembolism in Long-Term Care: Results of a Multicenter Educational Intervention Using Clinical Practice Guidelines: Part 2 of 2 (an AMDA Foundation Project). J. Am. Med. Dir. Assoc. (2011)
Eccles, M., Clapp, Z., Grimshaw, J., et al.: North of England evidence based guidelines development project: methods of guideline development. BMJ 312(7033), 760–762 (1996)
Echt, D.S., Liebson, P.R., Mitchell, L.B., et al.: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N. Engl. J. Med. 324(12), 781–788 (1991)
Eckardt, K.U., Kasiske, B.L.: Kidney disease: improving global outcomes. Nat. Rev. Nephrol. 5(11), 650–657 (2009)
Eddy, D.M.: Evidence-based medicine: a unified approach. Health Aff. (Millwood) 24(1), 9–17 (2005)
Eddy, D.M.: Variations in physician practice: the role of uncertainty. Health Aff. (Millwood) 3(2), 74–89 (1984)
Eknoyan, G., Beck, G.J., Cheung, A.K., et al.: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N. Engl. J. Med. 347(25), 2010–2019 (2002)
Elstein, A.S.: On the origins and development of evidence-based medicine and medical decision making. Inflamm. Res. 53(suppl. 2), S184–S189 (2004)
Engels, E.A., Falagas, M.E., Lau, J., Bennish, M.L.: Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. BMJ 316(7125), 110–116 (1998)
Feinstein, A.R.: Current problems and future challenges in randomized clinical trials. Circulation 70(5), 767–774 (1984)
Glasziou, P., Meats, E., Heneghan, C., Shepperd, S.: What is missing from descriptions of treatment in trials and reviews? BMJ 336(7659), 1472–1474 (2008)
Greer, N., Mosser, G., Logan, G., Halaas, G.W.: A practical approach to evidence grading. Jt. Comm. J. Qual. Improv. 26(12), 700–712 (2000)
Grol, R.: Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med. Care 39(8 suppl. 2), II46–II54 (2001)
Grol, R., Grimshaw, J.: From best evidence to best practice: effective implementation of change in patients’ care. Lancet 362(9391), 1225–1230 (2003)
Grol, R., Wensing, M.: What drives change? Barriers to and incentives for achieving evidence-based practice. Med. J. Aust. 180(6), S57–S60 (2004)
Guyatt, G., Vist, G., Falck-Ytter, Y., et al.: An emerging consensus on grading recommendations? Evid. Based Med. 11(1), 2–4 (2006)
Guyatt, G.H., Oxman, A.D., Vist, G.E., et al.: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650), 924–926 (2008)
Guyatt, G.H., Sackett, D.L., Sinclair, J.C., et al.: Users’ guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 274(22), 1800–1804 (1995)
Harrison, J.: Oxford handbook of key clinical evidence. Oxford University Press, Oxford (2009)
Hirsh, J., Guyatt, G.: Clinical experts or methodologists to write clinical guidelines. Lancet 374(9686), 273–275 (2009)
Hornberger, J.C.: The hemodialysis prescription and cost effectiveness. Renal Physicians Association Working Committee on Clinical Guidelines. J. Am. Soc. Nephrol. 4(4), 1021–1027 (1993)
Hulley, S., Grady, D., Bush, T., et al.: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280(7), 605–613 (1998)
Humphrey, L.L., Chan, B.K., Sox, H.C.: Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann. Intern. Med. 137(4), 273–284 (2002)
Ioannidis, J.P., Haidich, A.B., Pappa, M., et al.: Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286(7), 821–830 (2001)
Juni, P., Altman, D.G., Egger, M.: Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 323(7303), 42–46 (2001)
K/DOQI Workgroup. K/DOQI Clinical practice guidelines for cardiovascular disease in dialysis patients. Am. J. Kidney Dis. 45(4 suppl. 3), S1–S153 (2005)
K/DOQI Workgroup. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39(2 suppl. 1), S1–S266 (2002)
K/DOQI Workgroup. K/DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am. J. Kidney Dis. 30(3), S150–S191 (1997)
Lesho, E.P., Myers, C.P., Ott, M., et al.: Do clinical practice guidelines improve processes or outcomes in primary care? Mil. Med. 170(3), 243–246 (2005)
Lusted, L.B.: Introduction to medical decision making. Charles C Thomas Pub. Ltd., Springfield (1968)
Meehl, P.E.: Clinical versus statistical prediction; a theoretical analysis and a review of the evidence. University of Minnesota Press, Minneapolis (1954)
Medical Research Council. STREPTOMYCIN treatment of pulmonary tuberculosis. Br. Med. J. 2(4582), 769–782 (1948)
Moher, D., Tetzlaff, J., Tricco, A.C., et al.: Epidemiology and reporting characteristics of systematic reviews. PLoS Med. 4(3), e78 (2007)
Naylor, C.D., Guyatt, G.H.: Users’ guides to the medical literature. X. How to use an article reporting variations in the outcomes of health services. The Evidence-Based Medicine Working Group. JAMA 275(7), 554–558 (1996)
Oh, S.W., Lee, H.J., Chin, H.J., Hwang, J.I.: Adherence to clinical practice guidelines and outcomes in diabetic patients. Int. J. Qual. Health Care 23(4), 413–419 (2011)
Paniagua, R., Amato, D., Vonesh, E., et al.: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J. Am. Soc. Nephrol. 13(5), 1307–1320 (2002)
Ploeg, J., Davies, B., Edwards, N., et al.: Factors influencing best-practice guideline implementation: lessons learned from administrators, nursing staff, and project leaders. Worldviews Evid. Based Nurs. 4(4), 210–219 (2007)
PLoS Medicine Editors. Many reviews are systematic but some are more transparent and completely reported than others. PLoS Med. 4(3), e147 (2007)
Port, F.K., Pisoni, R.L., Bragg-Gresham, J.L., et al.: DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif. 22(1), 175–180 (2004)
Rangachari, P.K.: Evidence-based medicine: old French wine with a new Canadian label? J. R. Soc. Med. 90(5), 5–280 (1997)
Rossouw, J.E., Anderson, G.L., Prentice, R.L., et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288(3), 321–333 (2002)
Sackett, D.L., Rosenberg, W.M., Gray, J.A., et al.: Evidence based medicine: what it is and what it isn’t. BMJ 312(7023), 71–72 (1996)
Sacks, H., Chalmers, T.C., Smith Jr., H.: Randomized versus historical controls for clinical trials. Am. J. Med. 72(2), 233–240 (1982)
Schulz, K.F., Altman, D.G., Moher, D.: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340, c332 (2010)
Schuster, M.A., Mcglynn, E.A., Brook, R.H.: How good is the quality of health care in the United States? Milbank Q. 76(4), 517–563 (1998)
Strippoli, G.F., Craig, J.C., Schena, F.P.: The number, quality, and coverage of randomized controlled trials in nephrology. J. Am. Soc. Nephrol. 15(2), 411–419 (2004)
Sung, N.S., Crowley Jr., W.F., Genel, M., et al.: Central challenges facing the national clinical research enterprise. JAMA 289(10), 1278–1287 (2003)
Taylor, M., Dlamini, S.B., Kagoro, H., et al.: Understanding high school students’ risk behaviors to help reduce the HIV/AIDS epidemic in KwaZulu-Natal, South Africa. J. Sch. Health. 73(3), 97–100 (2003)
Timmermans, S., Mauck, A.: The promises and pitfalls of evidence-based medicine. Health Aff. (Millwood) 24(1), 18–28 (2005)
Uhlig, K., Macleod, A., Craig, J., et al.: Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 70(12), 2058–2065 (2006)
Weingarten, S.: Using practice guideline compendiums to provide better preventive care. Ann. Intern. Med. 130(5), 454–458 (1999)
Wennberg, J., Gittelsohn, A.: Small area variations in health care delivery. Science 182(117), 1102–1108 (1973)
West, S., King, V., Carey, T.S., et al.: Systems to rate the strength of scientific evidence. Evid. Rep. Technol. Assess. (Summ) 47, 1–11 (2002)
Westfall, J.M., Mold, J., Fagnan, L.: Practice-based research–"Blue Highways on the NIH roadmap. JAMA 297(4), 403–406 (2007)
Wikstrom, B., Jacobson, S.H., Bragg-Gresham, J., et al.: Dialysis Outcomes and Practice Patterns Study estimate of patient life-years attributable to modifiable haemodialysis practices in Sweden. Scand J. Urol. Nephrol. 44(2), 113–120 (2010)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kitzler, T.M., Levin, N.W. (2013). Clinical Practice Guidelines in Nephrology. In: Azar, A. (eds) Modeling and Control of Dialysis Systems. Studies in Computational Intelligence, vol 405. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27558-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-27558-6_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-27557-9
Online ISBN: 978-3-642-27558-6
eBook Packages: EngineeringEngineering (R0)